AFFY  Affymax Inc.




Consumer Durables


Major Pharmaceuticals

Market Cap.


Current Price

+0.000 (+0.000%)

Book Price

Overvalued by 368.03%
Financial Institution

Company Metrics

  • P/E 0.915
  • P/S 66.948
  • P/B 0.543
  • EPS 0.082
  • Dividend 0 / 0%
  • Avg. Vol. 30,713.00
  • Shares 37.47M
  • Market Cap. 2.81M

Company Description

Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. The company is developing Hematide, which is in Phase III clinical trials for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood ... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Affymax, Inc. Announces a Special Cash Distribution and the Appointment of a ...
Business Wire (press release) - Nov 26, 2014
CUPERTINO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (OTCQB: AFFY) today announced that its Board of Directors has declared a special cash distribution to shareholders in the amount of $0.05 per share.
Affymax Likely Worthless: Omontys Kills At Least 9x More People Than Epogen
Seeking Alpha - Aug 28, 2013
Affymax, Inc. (OTCPK:AFFY) is a shell company that owns potential future royalty and milestone payments associated with the recently recalled drug Omontys (peginesatide).
Affymax: Emerging Data Supports Conclusion Omontys Likely Dead
Seeking Alpha - Nov 12, 2013
After reviewing the summary adverse event report data highlighting a shocking number of deaths associated with Omontys, (discussed here), we followed-up with the FDA to request more information.
Delisting of Securities of Telestone Technologies Corp, Affymax, Inc., Exide ...
GlobeNewswire (press release) - Jul 18, 2013
Delisting of Securities of Telestone Technologies Corp, Affymax, Inc., Exide Technologies, Orchard Supply Hardware Stores Corporation, Spire Corporation and Shengkai Innovations, Inc. From The NASDAQ Stock Market ...
Affymax, Inc. (OTCMKTS:AFFY) Crashes After Losing Partner
HotStocked - Jun 17, 2014
Yesterday's market session was a real disaster for Affymax, Inc. (OTCMKTS:AFFY, AFFY message board). Once the 8-K announcing that the partnership AFFY had with Takeda has been terminated affected the market, the company lost 54.55% of its share ...
Affymax, Inc. (NASDAQ:AFFY) Stock Shoots Up
HotStocked - Aug 9, 2010
On Friday, one month after the last deep plunge of Affymax, Inc. (NASDAQ:AFFY, AFFY message board) stock, a completely different scenario proved investor willingness to support the shares' upward direction.
The end for Affymax
Seeking Alpha - Jun 24, 2014
With no hope for a return to the market for Omontys, Affymax's (AFFY) BOD approves the liquidation and dissolution of the company, subject to shareholder approval.
Affymax Board Announces Decision to Dissolve the Company - Business Wire (press release)
Affymax Board Approves Dissolving Troubled Company - Genetic Engineering News
Affymax stock plunges 85 percent on drug recall
Reuters - Feb 25, 2013
Shares of Affymax Inc AFFY.O fell 85 percent after it said serious adverse reactions, including death, were reported among some of those using its sole commercial product, anemia drug Omontys.
Down 85%! Why Affymax Is Getting Crushed This Morning - Motley Fool
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of ... - Business Wire (press release)
How to Protect Your Retirement Plans
Benzinga - Jun 26, 2013
Managed properly, retirement plans enhance wealth due to the power of compound interest. Ideally, the beneficiary saves enough money to live comfortably during retirement without having to worry about outliving his savings.
Affymax CEO steps down as restructuring firm steps in
San Francisco Business Times (blog) - May 15, 2013
Palo Alto-based Affymax (NASDAQ: AFFY) said it will appoint a Brenner Group representative as CEO "in the coming weeks" and name Brenner Group personnel as company officers.